Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons: biological and clinical effects.

B E Nelson1, E C Borden

  • 1Department of Human Oncology, University of Wisconsin Clinical Cancer Center, Madison 53792.

Seminars in Surgical Oncology
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics.

Immuno-oncology technology·2025
Same author

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Oncogene·2012
Same author

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Oncogene·2011
Same author

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

British journal of cancer·2011
Same author

Slow-scan television system.

Applied optics·2010
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Interferons are crucial immune system modifiers with antiviral and antitumor effects. Research shows their efficacy in treating some cancers, with ongoing studies exploring combination therapies.

Area of Science:

  • Immunology and Molecular Biology
  • Biotechnology and Genetic Engineering

Background:

  • Interferons (IFNs) are key biological response modifiers within the immune system.
  • Specific types like Interferon-alpha, -beta, and -gamma have been identified and characterized.
  • Recombinant DNA technology enables the production of these proteins.

Purpose of the Study:

  • To summarize the diverse biological actions of interferons.
  • To highlight their potential therapeutic applications in oncology.
  • To discuss ongoing research into combination therapies.

Main Methods:

  • Characterization of interferon nucleotide sequences.
  • Production of interferon proteins using recombinant DNA technology.
  • Review of clinical trial data and ongoing studies.

Related Experiment Videos

Main Results:

  • Interferons exhibit broad actions including enhancing natural killer cell activity and antigen expression.
  • They activate macrophages and possess antiviral, antiproliferative, and antitumor effects.
  • Clinical trials confirm interferon efficacy in certain malignancies.

Conclusions:

  • Interferons are versatile immune modulators with established antitumor properties.
  • Their combination with other agents is a promising area for cancer treatment research.
  • Further clinical investigations are warranted to optimize therapeutic strategies.